Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial

Avihingsanon, Anchalee; Hughes, Michael D.; Salata, Robert; Godfrey, Catherine; McCarthy, Caitlyn; Mugyenyi, Peter; Hogg, Evelyn; Gross, Robert; Cardoso, Sandra W.; Bukuru, Aggrey; Makanga, Mumbi; Badal-Aesen, Sharlaa; Mave, Vidya; Ndege, Beatrice Wangari; Fontain, Sandy Nerette; Samaneka, Wadzanai; Secours, Rode; Schalkwyk, Marije Van; Mngqibisa, Rosie; Mohapi, Lerato; Valencia, Javier; Sugandhavesa, Patcharaphan; Montalban, Esmelda; Munyanga, Cornelius; Chagomerana, Maganizo; Santos, Breno R.; Kumarasamy, Nagalingeswaran; Kanyama, Cecilia; Schooley, Robert T.; Mellors, John W.; Wallis, Carole L.; Collier, Ann C.; Grinsztejn, Beatriz

Avihingsanon, Anchalee; Hughes, Michael D.; Salata, Robert; Godfrey, Catherine; McCarthy, Caitlyn; Mugyenyi, Peter; Hogg, Evelyn; Gross, Robert; Cardoso, Sandra W.; Bukuru, Aggrey; Makanga, Mumbi; Badal-Aesen, Sharlaa; Mave, Vidya; Ndege, Beatrice Wangari; Fontain, Sandy Nerette; Samaneka, Wadzanai; Secours, Rode; Schalkwyk, Marije Van; Mngqibisa, Rosie; Mohapi, Lerato; Valencia, Javier; Sugandhavesa, Patcharaphan; Montalban, Esmelda; Munyanga, Cornelius; Chagomerana, Maganizo; Santos, Breno R.; Kumarasamy, Nagalingeswaran; Kanyama, Cecilia; Schooley, Robert T.; Mellors, John W.; Wallis, Carole L.; Collier, Ann C.; Grinsztejn, Beatriz.

Afiliação

Avihingsanon, Anchalee; Chulalongkorn University. Faculty of Medicine. Thai Red Cross AIDS Research Centre and Centre of Excellence in Tuberculosis. HIV-NAT. Bangkok, Thailand..

Article em En | ARCA | ID: arc-55522